Agenda

For post-conference comments and questions please email to: CGVHD2020@mail.nih.gov

Steering Committee: Steven Pavletic, Stephanie Lee, Kirk Schultz, Daniel Wolff, Hildegard Greinix, Sophie Paczesny, Bruce Blazar, Stefanie Sarantopoulos, Joseph Pidala, Corey Cutler, Gerard Socie, Paul Martin, Meredith Cowden.

 

For a downloadable version of the agenda, please click here.

Wednesday, Nov 18 Thursday, Nov 19 Friday, Nov 20

Wednesday, November 18, 2020

SESSION 1
10:00 am - 10:15 am EST
Welcome and Introductions

Steven Pavletic, M.D., Center for Cancer Research, NCI

Brigitte Widemann, M.D., Center for Cancer Research, NCI

Working Group 1: Report: Etiology and Prevention of Chronic GVHD

Session Chair: Steven Pavletic, M.D., Center for Cancer Research, NCI

Moderator: Paul Martin, M.D., Fred Hutchinson Cancer Research Center

Presenters:

Stefanie Sarantopoulos, M.D., Ph.D., Duke University

Gerard Socie, M.D., Ph.D., St-Louis Hospital

10:15 am - 10:35 am EST
Overview of the Paper (20 minutes)

Stefanie Sarantopoulos, M.D., Ph.D., Duke University

Gerard Socie, M.D., Ph.D., St-Louis Hospital

10:35 am - 11:10 am EST
Critique of the Paper (20 minutes) and response (15 minutes)

Reviewers:

Nicolaus Kroeger, M.D., University of Hamburg

Ryo Nakamura, M.D., City of Hope Cancer Center

John Dipersio, M.D., Washington University

11:10 am - 11:50 am EST
Open discussion of the Paper (40 minutes)

Live Q/A discussion is open to Working Group 1 panel and all participants.

11:50 am - 11:55 am EST
Moderator summarizes themes and next steps (5 minutes)
11:55 am - 12:00 pm EST
Final comments by Chair (5 minutes)
12:00 pm - 01:00 pm EST
LUNCH
SESSION 2
01:00 pm - 01:05 pm EST
Introduction

Chair: Kirk Schultz, M.D., University of British Columbia

Moderator: Stephanie Lee, M.D., Fred Hutchinson Cancer Research Center

 

Working Group 2a:  Report: Clinical Implementation and Early Diagnosis of Chronic GVHD

Presenters:

Carrie Kitko, M.D., Vanderbilt University

Corey Cutler, M.D., M.P.H, FRCPC, Dana Farber Cancer Institute

01:05 pm - 01:20 pm EST
Overview of the Paper (15 minutes)

Carrie Kitko, M.D., Vanderbilt University

Corey Cutler, M.D., M.P.H, FRCPC, Dana Farber Cancer Institute

01:20 pm - 01:50 pm EST
Critique of the Paper (20 minutes) and response (10 minutes)

Reviewers:

Mark Juckett, M.D., University of Wisconsin

George Chen, M.D., University of Rochester

Rafael Duarte, M.D., University Puerta de Hierro Majadahonda

Working Group 2b: Report: Preemptive Therapy of Chronic GVHD

Presenters:

Joseph Pidala, M.D, Ph.D., Moffitt Cancer Center

Geoffrey Hill, M.D., FRACP, FRCPA, Fred Hutchinson Cancer Research Center

01:50 pm - 02:05 pm EST
Overview of the Paper (15 minutes)

Joseph Pidala, M.D, Ph.D., Moffitt Cancer Center

Geoffrey Hill, M.D., FRACP, FRCPA, Fred Hutchinson Cancer Research Center

02:05 pm - 02:35 pm EST
Critique of the Paper (20 minutes) and response (10 minutes)

Reviewers:

Franco Locatelli, M.D., University of Pavia

Areej El-Jawahri, M.D., Massachusetts General Hospital

Robert Soiffer, M.D., Dana Farber Cancer Institute

02:35 pm - 03:05 pm EST
Open discussion of the Papers (30 minutes)

Live Q&A discussion is open to Working Group 2 panel and all participants.

03:05 pm - 03:10 pm EST
Moderator summarizes themes and next steps (5 minutes)
03:10 pm - 03:15 pm EST
Final comments by Chair (5 minutes)
03:15 pm EST
Adjourn

Thursday, November 19, 2020

SESSION 3
10:00 am - 10:05 am EST
Introduction

Session Chair: Daniel Wolff, M.D., University of Regensburg

Moderator: Paul Martin, M.D., Fred Hutchinson Cancer Research Center

Working Group 3: Report: Treatment of Chronic GVHD

Presenters:

Zachariah DeFilip, M.D., Massachusetts General Hospital,

Daniel Couriel, M.D., M.S., University of Utah,

Bruce Blazar, M.D., University of Minnesota,

Hildegard Greinix, M.D., University of Graz

10:05 am - 10:25 am EST
Overview of the Paper (20 minutes)

Zachariah DeFilip, M.D., Massachusetts General Hospital,

Daniel Couriel, M.D., M.S., University of Utah,

Bruce Blazar, M.D., University of Minnesota,

Hildegard Greinix, M.D., University of Graz

10:25 am - 11:00 am EST
Critique of the Paper (20 minutes) and response (15 minutes)

Reviewers:

Daniel Weisdorf, M.D., University of Minnesota

Keith Sullivan. M.D., Duke University

Catherine Lee, University of Utah

11:00 am - 11:50 am EST
Open discussion of the Paper (50 minutes)

Live Q&A discussion is open to Working Group 3 panel and all participants

11:50 am - 11:55 am EST
Moderator summarizes themes and next steps (5 minutes)
11:55 am - 12:00 pm EST
Final comments by Chair (5 minutes)
12:00 pm - 01:00 pm EST
LUNCH
SESSION 4
01:00 pm - 01:05 pm EST
Introduction

Session Chairs:

Kirk Schultz, M.D., University of British Columbia

Steven Pavletic, M.D., Center for Cancer Research, NCI

Moderator: Stephanie Lee, M.D., Fred Hutchinson Cancer Research Center

Working Group 4:  Report: Highly Morbid Forms of Chronic GVHD

Presenters:

Daniel Wolff, M.D., University of Regensburg

Sophie Paczesny, M.D., University of South Carolina

01:05 pm - 01:25 pm EST
Overview of the Paper (20 minutes)

Daniel Wolff, M.D., University of Regensburg

Sophie Paczesny, M.D., University of South Carolina

01:25 pm - 02:00 pm EST
Critique of the Paper (20 minutes) and response (15 minutes)

Reviewers:

Jose Antonio Perez-Simon, M.D., Instituto de Biomedicina de Sevilla

Doris Ponce, M.D. Memorial Sloan-Kettering Cancer Center

Andrew Harris, M.D., University of Utah

02:00 pm - 02:50 pm EST
Open Discussion of the Paper (50 minutes)

Live Q&A discussion is open to Working Group 4 panel and all participants.

02:50 pm - 02:55 pm EST
Moderator summarizes themes and next steps (5 minutes)
02:55 pm - 03:00 pm EST
Final comments by Chair (5 min)
03:00 pm EST
Adjourn

Friday, November 20, 2020

SESSION 5
10:00 am - 10:05 am EST
Introduction

Session Chairs:

Steven Pavletic, M.D., Center for Cancer Research, NCI

Paul Martin, M.D., Fred Hutchinson Cancer Research Center

Industry Summit

Presenters:

Corey Cutler, M.D., M.P.H., FRCPC, Dana Farber Cancer Institute

Daniel Couriel, M.D., M.S., University of Utah

10:05 am - 10:15 am EST
Summit Goals
10:15 am - 10:25 am EST
Conclusions of the NIH Working Groups discussion
10:25 am - 10:45 am EST
Challenges and Plans for Improved Academia and Industry Collaboration
10:45 am - 12:00 pm EST
Open Discussion

Live Q&A discussion is open to all participants

12:00 pm - 01:00 pm EST
LUNCH
SESSION 6
01:00 pm - 01:05 pm EST
Introduction and Goals

Session Chairs:

Stephanie Lee, M.D., Fred Hutchinson Cancer Research Center

Kirk Schultz, M.D., University of British Columbia

Patient Advocacy Summit

Moderators:

Meredith Cowden, M.A., LPCC-S, Cowden Foundation

Daniel Wolff, M.D., University of Regensburg

01:05 pm - 01:30 pm EST
Four NIH Consensus Working Group Presentation

Presenters:

Katie Schoeppner, M.S.W., LICSW, Be The Match

Michelle Bishop, Ph.D., Coping with Cancer and Caregiving, LLC

Susan Stewart, BMT InfoNet

Meredith Cowden, M.A., LPCC-S, Cowden Foundation

Peggy Burkhard, NbmtLINK

Guy Bouguet, France Lymphome Espoir

Christina Ferraro, C.N.P., Cleveland Clinic Foundation

Chiara DeBiase, M.Sc., B.Sc., MCSP, Anthony Nolan

01:30 pm - 01:35 pm EST
Menti Test Survey

Helene Schoemans, M.D., Ph.D., University Hospitals Leuven, KU Leuven, Leuven, Belgium

01:35 pm - 01:50 pm EST
Crucial Advocacy Topics

Patient and Caregiver Education and Support

Presenter: Katie Schoeppner, M.S.W., LICSW, Be The Match

01:50 pm - 02:05 pm EST
Neurocognitive and Psychosocial Impact

Presenter: Susan Stewart, BMT InfoNet

02:05 pm - 02:20 pm EST
Survivorship and Long-Term Care

Presenters:

Naomi Pineda, Patient  

Christina Ferraro, C.N.P., Cleveland Clinic Foundation

02:20 pm - 02:35 pm EST
Menti Survey

Helene Schoemans, M.D., Ph.D., University Hospitals Leuven, KU Leuven, Leuven, Belgium

02:35 pm - 03:00 pm EST
Open Discussion

Live Q&A discussion open to all participants

03:00 pm - 03:15 pm EST
Closing Remarks

Meredith Cowden, M.A., LPCC-S, Cowden Foundation